Organisers are calling for entrants for this year's Vet Charity Challenge, an outdoor sporting fundraiser which also serves as a team building event for practices.
Competitors take part in walking, running, cycling and kayaking challenges, along with some orienteering and mental and physical tasks, in teams of four.
The event will take place on Saturday 28th September at Pershore College, Worcestershire.
Organisers say the Vet Charity Challenge has been designed for every level of fitness and success on the day depends very much on how well each team member works together, rather than physical fitness.
Jason Rogers, one of the VCC organisers said: "Teams are registering every day and we are delighted with the response. But there are a few team spaces left, so I urge practices to register a team of four online now at: www.vetcharitychallenge.co.uk."
The Vet Charity Challenge 2012 raised a total of £21,000, which was shared between three animal charities. The event in 2013 will raise funds for Hearing Dogs for the Deaf, SPANA and Animals Asia.
Alstoe Ltd has launched Tempora, a chewable, flavoured, spironolactone tablet for dogs, indicated for the treatment of congestive heart failure (CHF) arising from mitral valve disease.
Alstoe says Tempora's flavouring technology, tablet shape and two and four way break tablets facilitate ease of use and should improve compliance. The company also highlights the affordability of the new product, which can be used alone or in conjunction with standard therapies.
According to Alstoe, it is estimated that in 75% of dogs with CHF, degenerative mitral valve disease is the underlying cause. The company says spironolactone shows clear benefits in treating mxyomatous mitral valve disease (MMVD) in dogs: acting as an aldosterone receptor antagonist it counteracts the negative consequences of aldosterone production such as myocardial fibrosis and myocardial and vascular remodelling.
To support the new product, Alstoe has designed a Sleep Respiratory Rate (SRR) chart to assist veterinary professionals with ongoing monitoring of their canine patients condition and response to treatment. The chart is available as a printable download or in pads. The company is also offering lunchtime practice seminars.
Tempora is available as 10mg, 50mg and 100mg tablets.
For further information, contact Alstoe Animal Health on 01347 878606, or via e-mail: adelaideellerington@alstoe.co.uk, or visit www.alstoe.co.uk
Richard Hepburn MRCVS has launched what is thought to be the world's first equine gastric ulcer study, designed to improve understanding and knowledge of ulceration in performance horses.
Mr Hepburn is conducting the InnerVision study of performance horses, which is being championed by the University of Liverpool, as part of his PhD.
21 appointed practices across the UK are participating in the study, and with each practice scoping between 10 and 20 animals, it will include well over 200 performance horses. Mr Hepburn said: "Gastric ulceration in sports horses is poorly understood, especially compared with racehorses. But what we do know is that it's a very important factor in the performance and well-being of many horses in training and competition."
2012 Paralympic Gold medallist Deb Criddle MBE also attended the launch event. She explained the difference that regular gastroscopy and ulcer management of Paralympic team horses had made to her success. Speaking about her Beijing ride, Pavaroti, she said: "If it weren't for the diagnosis and treatment of Pavaroti's ulcers I don't know what we'd have done. I would probably have had to withdraw him from training, so it made the difference between our partnership continuing or not".
Mr Hepburn expects a prevalence of approximately 60% and, keen to increase understanding of glandular ulceration, participants are being tasked to scope all areas of the stomach, pylorus and duodenum to ensure that every incidence of ulceration is diagnosed and recorded.
He says he is particularly eager to find out more about glandular disease, which hitherto has had little research: "Glandular disease appears to have a very different aetiology to squamous ulceration, and often presents with different signs. We also believe that prevalence of glandular ulceration is most common in sports horses."
"We hope that publication of this study will help all equine vets in their work with performance horses and the quest to prevent and manage equine ulcers," he added.
Merial is supporting the study with management assistance.
MSD Animal Health has announced a new claim for Bovilis BVD and Bovilis IBR Marker Live vaccines which means they can be mixed and administered in a single syringe.
MSD says the new mixing claim will offer significant advantages in herd health planning when controlling two of the more important infectious diseases in cattle.
Bovine Viral Diarrhoea (BVD) and Infectious Bovine Rhinotracheitis (IBR) remain major threats to cattle health and productivity. Vaccinations are commonly given at housing and/or turnout, which are both busy times for veterinary surgeons and on the farm in the herd health planning calendar.
The mixed vaccines are suitable only for booster vaccinations of animals from 15 months of age previously vaccinated separately with Bovilis IBR Marker Live and Bovilis BVD. The mixed vaccine needs to be used within three hours.
MSD says the mixing procedure is clear and easy, but there is an instructional video here: http://www.msd-animal-health.co.uk/Mixing_bovilis_BVD_Bovilis_IBR-Marker_Live.aspx
CVS has announced the acquisition of four further veterinary practices bringing the total number of practices it owns across the UK to 92 operating from 253 sites.
The latest practices to join CVS are: Crescent Veterinary Clinic Ltd, Melton Mowbray; Miller & Swann Veterinary Surgery, Elgin; West Mount Vets, Halifax and Anchorage Veterinary Hospital, Acle.
CVS now employs more than 2,300 staff at its veterinary practices and surgeries across the UK and in its related veterinary businesses, including an online pharmacy, two pet crematoriums and six veterinary laboratories.
Novartis Animal Health has launched Helping Hearts, a competition in which veterinary surgeons have the chance to brush up on their cardiology whilst at the same time triggering a donation to Hounds for Heroes and entering the running to win one of 10 Red Letter Day experiences.
To enter the competition, visit www.notjustoneheart.com.
Each entry triggers a donation of £1 to Hounds for Heroes, a charity which provides specially trained assistance dogs to injured and disabled men and women of both the UK Armed Forces and Civilian Emergency Services.
Hounds for Heroes was set up by Allen Parton, who was himself injured in service. Allen freely admits that he owes his life to Endal - a Labrador that developed skills beyond his initial basic training and who proved so inspiring to everyone who met him and that he was awarded the accolade 'Dog of the Millennium'. With three squadrons of puppies currently in basic training, there are hopefully a few more canine heroes like Endal waiting in the wings.
Senior Category Manager Cardiology/Nephrology Brock Abreu said: "Here at Novartis Animal Health, we are absolutely thrilled to be supporting such a life-changing and life-enhancing cause. I know this is a charity that many vets feel they can relate to and we are encouraging as many of them as possible to take part. I'd be delighted if we were inundated with entries and could make an impressive donation to Hounds for Heroes on behalf of vets across the country."
The competition is open till 31st December 2013.
Animalcare has announced the launch of a new epilepsy monitoring programme to support users of its Phenoleptil (phenobarbital) tablets.
As part of the programme, veterinary surgeons can have patients' phenobarbital plasma levels analysed by Carmichael Torrance Diagnostic Service (CTDS). CTDS Veterinary Director Nick Carmichael (RCVS Recognised Specialist in Veterinary Clinical Pathology) and his team will also be available both to interpret results and discuss all aspects of therapeutic monitoring at no extra cost.
In addition, veterinary surgeons can opt for additional chemistry, including bile acids to assess hepatic function plus haematology. All Phenoleptil users are eligible for 50% discount off these services.
Animalcare has also expanded the Phenoleptil range and launched new strength tablets of 25mg and 100mg. Presented as new "snap- tabs" with a four-way score for more accurate dosing, whatever the weight of the dog, this enables fine adjustments to be made thereafter, reducing the risk of sub-optimal dosing.
The 100 tablet packs are designed for quick and easy dispensing with flavoured tablets to aid compliance. The 12.5mg and 25mg strengths are the only phenobarbital tablets licensed for dogs under 12kg and make it possible to treat dogs as low as 2.5kg (assuming a 2.5mg/kg bid starting dose) in weight. The 100mg tablets are useful to treat larger dogs.
For more information, contact your local Animalcare representative.
Zea Sciences has announced that its natural rodenticide has been certified under the European Biocide Directive Program, known as Annex1/1A BPD 98/8EEC.
The rodenticide is made from powdered corn cob (PCC) which, according to Zea Sciences, causes rats and mice to die of hypovolemic shock within 4-7 days of starting to feed on it.
The company says PCC poses no health risk to human or non target animal species, such as cats, dogs and birds. It is also the first of its type and class to be officially acknowledged as using naturally biodegradable and environmentally friendly material.
PCC is available from a number of retail and trade outlets, under various different brand names. However, the company said that if there was sufficient interest by vets in stocking the pet-friendly product, it would look at making it available through veterinary wholesalers.
Martin Holland, Managing Director of Zea Sciences said: ''I hope the profession will help spread the word about PCC-based rodent control - it might mean you have to reach for the vitamin K a little less often."
Dechra Veterinary Products has launched Vitamin K1 tablets for dogs, which help reverse the effects of exposure to anticoagulant rodenticides.
The launch of the NFA-VPS licensed 50mg tablets means that veterinary professionals can have a ready supply of Vitamin K when treating animals which have been exposed or may have been exposed to serious poisoning. Previously, the tablets where only available as a special import certificate product following Dechra's acquisition of Eurovet.
Dechra Veterinary Products Brand Manager, Carol Morgan, said: "Vitamin K1 is an absolutely key therapy in the treatment of potential and accidental exposures to anticoagulant poisoning in animals, mainly in pet dogs. It helps to assist with blood clotting, and the treatment protocol advises continued oral therapy following an initial injectable preparation of Vitamin K.
"The Veterinary Poisons Information Service has received more than 6,000 calls so far this year to its helpline regarding suspected or confirmed poisoning of all types of animals, whether accidental or deliberate exposure.
"We had been able to offer the Vitamin K1 injection and tablets via a SIC, when previously sometimes only preparations for human use were available. Therefore, we are delighted to now launch a licensed tablet which will ensure a ready supply and speed of therapy for animals affected by anticoagulant rodenticides."
Carol added: "Anticoagulant poisoning queries are already the second most common type received by the Veterinary Poisons Information Service, and with the launch of these tablets, veterinary professions will be able to have a ready supply of vitamin K to hand. We would recommend that all practices consider stocking this product."
Vitamin K1 50mg tablets, for the treatment of anticoagulant poisoning following parenteral treatment, are available in boxes of 14 tablets, in blister packs of seven tablets.
For more information, please visit www.dechra.co.uk
Vets Now has produced a new set of guidelines for pet owners about how to deal with the top 10 emergency situations seen by the out-of-hours care provider.
The guidelines are presented as an infographic - which is free to download from the Vets Now website - which provides some basic steps to help owners deal with the more common emergency situations before being able to get their sick or injured pet to the vet.
Vets Now says it is hoping it will be deemed useful by other vets who are welcome to share the infographic on their social media sites and their websites, or display it in their waiting rooms.
Lisa Maxwell, Head of Client Care said: "Pet owners should always call a vet in an emergency and we promote that in the infographic. As emergency and critical care providers, we're used to dealing with owners who are scared, or in shock when they call us. What we hoped to achieve by creating the infographic, was to reassure pet owners that these situations happen all the time and to give them more sense of control of the situation. If more pet owners were aware of some of the basic actions they could perform at the scene, at the very least it could help owners cope more readily and keep their animals calm and, at best, it could save lives."
Lisa added: "These days, the fastest way to spread an important message seems to be through social media, so we've specifically designed this infographic to be shared on Facebook, Twitter, G+ etc, as well as practice websites.
"Our intention was to create a useful resource for practices across the UK - not just Vets Now clinics. If we all get behind this and make our clients aware, maybe we'll be going that extra mile by educating our clients and helping to save even more lives."
The infographic can be downloaded at www.vets-now.com/infographic
The British Equine Veterinary Association (BEVA) has released the results of a survey carried out earlier this year which has found that there may be up to 5 times as many veterinary graduates wanting to work in equine practice as there are jobs available.
The survey was carried out amongst the 2,500 vets and vet students who are members of BEVA to help ascertain manpower requirements of equine practices in the UK.
Of the 819 new veterinary graduates in the UK in 2012, BEVA says it estimates conservatively that between 10-15% intend to work in equine practice. Meanwhile, the extrapolated results of the survey suggest that in 2012 there was less than 1% growth in full time equine vet positions and as few as 24 new permanent jobs available in the UK.
BEVA says that in line with the survey's suggestion of restricted opportunities, some of its members are also finding that internships, commonly the domain of new graduates to gain paid, supervised experience in practice, are now often taken by vets with some post-graduate experience. Furthermore, unpaid externships, which traditionally gave vet students valuable work experience, appear to be being filled by unemployed veterinary graduates wanting to gain experience in order to improve their chances of securing a job in equine practice.
Tim Mair, a partner at Bell Equine Veterinary Clinic in Kent said: "Earlier this year we had more than 80 applications for just one internship. Several years ago we would expect 50 or so applications for an advertised intern post but now, without advertising at all, we are constantly receiving applications, not just from new graduates but also from those who have been qualified for a year or more."
Charlie Schreiber, a partner at Donnington Grove Veterinary Surgery in Berkshire, said: "We take on an average of two externs a month and over the past four years have had more than 350 applicants but their calibre is noticeably changing. We used to hear primarily from students but now it tends to be recent graduates or those who have already done a job in mixed practice and are keen to move into equine but can't find an internship."
Andrew Harrison, a partner at Three Counties Equine Hospital in Gloucestershire, said: "In addition to the numerous applications we received for our recently advertised internship position, we are inundated with unsolicited enquiries about job opportunities from recent veterinary graduates from across the globe. Our most recent advertisement for an equine veterinary nurse has attracted interest from a handful of recently qualified vets desperate to find work. This employment problem is not confined to internships; some of our recent interns have found it very difficult, if not impossible to find a job in horse practice, once they've completed their internship."
Amanda Piggot, a recent graduate, has first hand experience of the challenge of finding a suitable placement. She said: "I have always wanted to work in equine practice and my approach has been very strategic. It took me five months to find my current position at Kessock Equine Vets in Inverness, which necessitated moving 500 miles further north than I ideally wanted. For my next position I applied to Liphook twice and had no luck but I have now been accepted by Rossdales for a two year internship."
According to the British Veterinary Association (BVA) the problem isn't confined to equine practice. The Association's President Peter Jones said: "The findings of the BEVA survey make sober reading and reflect the growing concerns in the wider veterinary profession about opportunities for new graduates in all types of veterinary practice.
"The issue has recently been brought into sharp focus by the announcement of a new veterinary school opening at the University of Surrey in 2014, with many BVA and BEVA members worried about an oversupply of veterinary graduates into an already competitive market. We are expecting the results of the RCVS survey of recent graduates shortly and, alongside the findings of the BEVA survey, they will provide an evidence-base to build on as we continue to assess the UK veterinary manpower implications of potential new veterinary schools in the future."
BEVA is keen to help both potential employees and employers tackle the situation as constructively as possible. BEVA President Keith Chandler said: "BEVA is proud that equine practice is attractive to so many younger members of the profession and it can provide a rewarding and fulfilling career. However we urge all stakeholders to ensure that current and prospective veterinary students are fully aware of the very limited opportunities in equine practice. Most of all we urge the students themselves to consider carefully their career path and prospects before making their final decisions."
Next month the RCVS will be releasing details of a survey of vets who have graduated within the past five years and how easy they have found it to find a job that meets their needs.
Petplan has been awarded an Insurance Times Tech Award for its social media campaign entitled "Like & Donate", which was devised to support two animal charities, the Dogs Trust and Cats Protection.
As part of the campaign, pet lovers are being encouraged to donate a food pouch to either charity by "liking" the Petplan Facebook page; with one "like" equalling one pouch of food for either the cat or dog charity.
The Facebook app also allows Petplan's Facebook fans to track the progress of donations and encourage friends to visit the page and support their chosen charity. The initiative has resulted in over 48,000 food pouches being donated to the charities with the Cats Protection receiving over 29,000 "likes" and the Dogs Trust gaining 19,500.
Petplan's Head of Marketing, Isabella von Mesterhazy said: "We are delighted our Like & Donate campaign has been awarded Best Use of Social Media. At Petplan we work with over 1,700 animal charities and our Like & Donate campaign has further helped to support the fantastic work of both the Dogs Trust and Cats Protection in rehoming dogs and cats across the UK."
To take part in Petplan's "Like & Donate" programme visit www.Facebook.co.uk/Petplan.
Virbac, in conjunction with the European Veterinary Dental Society, has launched an online dental charting system called the Electronic Veterinary Dental Scoring System for use by small animal practitioners.
The system aims to enhance the performance of clinicians conducting dentistry and to encourage a thorough review of the oral cavity during the annual check up.
The system allows you to record clinical findings on online dental charts and build up a history for each patient. There are also a series of tutorials to help in making clinical decisions. Virbac says the e-VDS system also encourages owner compliance with treatment regimes as it provides downloadable materials, including an assessment of their pet and follow up reports.
Dr Gottfried Morgenegg-Wegmüller, who was the EVDS project lead on this development, said: "It was always my vision to give veterinary dentistry the importance it deserves. The most effective way to achieve this is by targeting the general practitioner and encouraging them to have a closer look at the oral cavity of their patients."
Victoria Hudson, Product Manager for dental products at Virbac, said: "Poor dental health is a major issue for dogs and cats yet many practices are yet to capitalise on the opportunity to help increase the animal's welfare and health. Many owners are simply unaware of the importance of caring for their pet's teeth.
"The new e-VDS system is a great leap forward in dental care, offering not just electronic charting but a raft of additional support materials, all of which are practical and easy to use. We hope many practices will be keen to try it - and will soon be reaping the benefit!"
e-VDS is available free of charge on http://www.my-virbac.co.uk/, Virbac's practice support portal. Practices can also contact their territory manager for more details.
The RCVS has launched a mobile version of the Code of Professional Conduct for veterinary surgeons and veterinary nurses: an app for Android devices and a web app for Apple users.
Once installed, the app provides smartphone and tablet users with a mobile-friendly version of the Code and all 27 chapters of supporting guidance in their pockets, even when there is no network connection. Whenever the Code is updated, the latest version will be available to download the next time the device is online.
Head of Communications, Lizzie Lockett, said: "Our new app provides easy access to the Code, so busy veterinary surgeons and veterinary nurses can now keep our guidance to hand, even when out and about. It's never been easier to ensure that you're always working to the Code's principles of veterinary practice and professional responsibilities."
The app also offers a keyword search of the whole Code and supporting guidance, links to other sources of information and contact details for further advice over the phone or email.
To install the RCVS Code of Professional Conduct app on your android device, visit Google Play and search for 'RCVS code'. To install it on an Apple device, visit the RCVS Code web pages in the device's internet browser, click on the app link in the Code tool box on the right hand side, and follow the instructions.
Alternatively, a copy of the full Code and all supporting guidance can now be downloaded in PDF format from the RCVS website, date-stamped so that you know when it was last amended.
Visit www.rcvs.org.uk/code or www.rcvs.org.uk/vncode and see the 'Code tools' box for both the PDF and the web app.
The College says it would very much like feedback about the app, or suggestions for future apps - email Christine James in the Communications Department, on christinej@rcvs.org.uk.
Bimeda has announced the launch of Butagran Equi (phenylbutazone), to join its range of analgesics and anti-inflammatories.
Bimeda says that Butagran Equi provides rapid onset of activity with the added convenience for horse owners or professionals of being presented as an easy-to-administer sweetened powder.
Indications include musculo-skeletal conditions that require relief from pain and a reduction in the associated inflammation, including lameness associated with osteoarthritic conditions, bursitis, laminitis and soft tissue inflammation.
Head of Bimeda technical services Padraig Hyland MVB said: "Butagran Equi is particularly suited where continued mobility is considered desirable. It is also of value in limiting post-surgical inflammation, myositis and other soft tissue inflammation and can be used as an anti-pyretic where this is considered advisable, such as in viral respiratory infections. And being a sweetened powder it's quite straightforward for horse owners to administer and dose as prescribed."
He added: "Butagran Equi follows the launch of a number of new products and is proof our desire to provide a comprehensive and relevant equine portfolio backed up with first class technical support."
Novartis Animal Health has assumed marketing responsibilities for the joint health supplement Dasuquin in the United Kingdom and Ireland.
Dasuquin is a veterinary formulation developed to deliver advanced cartilage support in dogs. It contains a combination of glucosamine hydrochloride, chondroitin sulphate, avocado/soybean unsaponifiables (ASU), and tea polyphenols. Novartis says these compounds work synergistically to protect the cartilage, thereby playing an important role in supporting and maintaining joint health.
Novartis highlights a 2007 study which, according to the company, demonstrates that the combination of ASU, chondroitin sulphate, and glucosamine hydrochloride delivers incremental benefits compared to the combination of chondroitin sulphate and glucosamine hydrochloride alone.1
Dasuquin is available in flavoured chewable tablets in 80-count containers. Dasuquin is available in two strengths: small-to-medium dogs weighing between 5 and 25 kg and for large dogs weighing over 25 to 50 kg.
Gaynor Hillier, General Manager UK & Ireland Novartis Animal Health said: "This is a fitting addition to our overall orthopaedic health offering for vets and pet owners. Dasuquin brings vets and dog owners advanced joint health support with the next generation of the popular Cosequin family."
Dasuquin is available from Novartis Animal Health in the United Kingdom and Ireland from licensed veterinary wholesalers. For more information on Dasuquin, contact your Novartis Animal Health Territory Manager
Reference:
The Animal Health Trust has begun a pilot study to investigate a possible link between seasonal canine illness (SCI) and harvest mites, continuing an initial study on the possible cause of SCI funded by the Kennel Club.
SCI is a mystery illness which in recent years has made a number of dogs walked in woodlands suddenly become ill.
Cases of SCI are usually seen from August to November, with dogs showing clinical signs of vomiting, diarrhoea and/or lethargy within 24 to 72 hours of walking in woodland. Dog owners are advised to seek immediate veterinary advice should they see these signs in their dog following a woodland walk.
So far this year, there have been 49 cases in total reported to the AHT, from across all of its current investigation sites. A number of cases reported to the charity have shown evidence of harvest mite infestation.
Charlotte Robin, SCI Research Co-ordinator at the AHT, said: "To enable us to eliminate harvest mites as a potential cause of SCI, we are advising dog owners to treat their dogs with a fipronil spray directly before walking in woodlands."
There are currently no licenced products that will specifically prevent against harvest mites, however fipronil spray is believed to be effective in preventing other mites. The researchers believe that it is important that dog owners use the spray and not the spot-on treatment, which may not provide the same level of localised protection on vulnerable areas.
Charlotte added: "Dog owners need to be aware that using fipronil spray may not protect their dog from SCI, but it could protect them from harvest mites and other external parasites. What we are trying to do with this study is eliminate the harvest mite and other external parasites from our enquiries.
In addition to advising all dog owners walking their dogs in woodlands during autumn to use fipronil spray as an external parasite treatment, the AHT is working with the Sandringham Estate in Norfolk to offer to offer dog owners who wish to participate in the study access to the spray free of charge, if deemed appropriate by their veterinary surgeon.
As this is a prescription only medicine, the charity is issuing vouchers to dog owners which they can redeem for fipronil spray through their local vet practice, on the proviso their dog is deemed a suitable candidate by their vet.
Dog owners who meet the criteria and wish to participate in the study will be required to complete a SCI online questionnaire following their visit to the Estate, and an additional follow-up questionnaire regarding the pilot study, regardless of whether their dog was taken ill or not.
You can register to take part in the pilot study at www.aht.org.uk/scipilotstudy
Image courtesy: Luc Viatour / www.Lucnix.be
A debate held at BEVA Congress last month ended with more than 70% of voters disagreeing with the motion: this house believes that new vet schools will benefit equine veterinary practice in the UK.
The result reflects a recent industry survey indicating that up to five times as many veterinary graduates may be seeking work in equine practice as there are jobs available.
Chris Proudman, founding head of Surrey University's new School of Veterinary Medicine and Mark Bowen, Associate Professor of Veterinary Internal Medicine at the University of Nottingham's School of Veterinary Medicine and Science, advocated that new UK vet schools are important for the advancement of the profession.
Mark Bowen said: "New UK vet schools will benefit the profession by improving the standards of veterinary education and creating what the consumer wants." He argued that new schools would help improve teaching methods and clinical training, while the resultant smaller class sizes would provide greater opportunities for hands on training. Competition would also help to drive up standards and inspire other universities to instigate much-needed changes such as focusing on quality of teaching rather than research.
Chris Proudman emphasised the flexibility of a new vet school to be progressive and innovative in both curriculum design and teaching delivery. He said: "Designing a curriculum from scratch allows novel approaches to partnership working and to the One Health agenda. New schools can deliver veterinary graduates better equipped with the skills and knowledge to be the veterinary leaders of the future."
The proposers also reasoned that if school leavers cannot find a place in a UK vet school they can now attend English language veterinary schools in universities across the EU, many of which do not have European accreditation to ensure standards of education. Therefore the increase in numbers of veterinary graduates is irresistible and the authorities can only influence the numbers trained in the UK and govern the high quality of teaching that is provided in the UK.
Alastair Welch, a partner at Donnington Grove Veterinary Group in Berkshire and Lucy Grieve, vet at Darley Pre-Training in Newmarket, staunchly countered the motion. They maintained that new vet schools would have a detrimental impact on the industry over the longer term and that their introduction demonstrated a slackening of the RCVS's management of the profession.
Alastair said: "Both anecdotal and empirical data suggest that becoming a horse vet has never been harder. The seemingly endless supply of hard-working, well-qualified school leavers determined to become equine vets provides universities with a reliable income stream for years to come but at what cost? I remain to be convinced that we will not end up educating veterinary graduates who cannot find a position in their intended career."
Lucy contended that it was irresponsible and immoral to allow individuals to commit five or six years, and tens of thousands of pounds, towards a veterinary career without them first being made aware of the limited opportunities available in very popular sectors of the profession such as equine practice.
Paul Jepson, President of BEVA, said: "With more than 70% of voters opposing the motion there is clearly a discernable level of disquiet amongst BEVA members about the current job market in equine practice and the further dilution of opportunities that increased numbers of graduates will create."
To help address the growing challenges faced by new graduates BEVA has recently introduced an Internship Awareness Programme (IAP). The scheme aims to help students and vets navigate the opportunities available as an intern and helps equine veterinary practices to find the most suitable employees for their practice.
You should be able to view the debate here: http://www.fsmevents.com/beva/congress13-session34. If not, the debate can be viewed on the BEVA website by following these instructions. Click the Webinar tab. Then click register. Then complete the £0 transaction and you will be able to access the free webinars. Select 'Free sessions' (Click the + symbol). Select 'Current Affairs: New vet schools - supply and demand?'
Virbac is offering a free Rapid Romanowsky stain kit and Coplin jars to practices buying easOtic and Epi-Otic in a new promotion which runs until the end of October.
easOtic is Virbac's treatment for otitis externa. It features a 1ml airless pump for precise measurement and an award-winning bottle design to aid compliance by ensuring easy and accurate application.
Epi-Otic is Virbac's antibacterial and antifungal ear cleaner for use in routine cleaning. It is pH neutral and contains sodium docusate, which dries the ear canal after application.
Practices making a qualifying purchase of both products will receive the Stain Kit, comprising the three staining solutions and three Coplin jars, free of charge.
For further information, contact your Virbac Territory Manager.
The BSAVA has launched the BSAVA Manual of Canine and Feline Radiography and Radiology with a new introductory text aimed at veterinary students, nurses and new graduates.
The Association says confident radiographic interpretation presents a considerable challenge and the BSAVA Manual of Canine and Feline Radiography and Radiology provides a comprehensive review of the approach to radiological interpretation, the range of variants and the key fundamental principles and their application to common diseases.
The manual features high quality radiographic reproductions demonstrating normal anatomy and key aspects of interpretation, as well as illustrations showing patient positioning and the practical approach that is the hallmark of the BSAVA manuals.
The book contains the following contents:
An extra feature is the CD, which contains all the radiographic images from the manual, so that readers can view the many images at an enlarged size.
The manual is available from October and can be ordered from www.bsava.com.
The RCVS Disciplinary Committee has suspended a London-based veterinary surgeon from the Register for six months, having found that her falsification of clinical records amounted to serious professional misconduct.
At the two-day hearing, Dr Nicola Ersilova was charged with, and admitted to, three separate incidences of false and dishonest clinical record keeping following her treatment of a collapsed cat, whilst working at Vets Now in Thamesmead, London.
The Committee heard how Dr Ersilova had suspected that Lafite the cat, belonging to Mr Yingzhan Xiao, had been poisoned, so administered fluids and treated her with Lidocaine. A lay colleague, who was assisting with the treatment, subsequently observed Dr Ersilova standing staring at the cat, which had stopped breathing, then leaving the room to go and speak to Mr Xiao. The lay colleague's evidence confirmed to the Committee that Lafite's heart was still beating at this point, and that Dr Ersilova was then heard telling Mr Xiao that Lafite had died while being treated. The lay colleague later discovered that Dr Ersilova had listed calcium gluconate on Mr Xiao's bill and not Lidocaine and, when she questioned the entry, Dr Ersilova told her she was worried about getting into trouble if she had listed Lidocaine.
Whilst reporting these irregularities to the senior veterinary surgeon at Vets Now, the lay colleague noticed that Dr Ersilova had also written "CPR unsuccessful" in the notes, although she was certain CPR (cardiopulmonary resuscitation) had not been attempted.
During a subsequent Vets Now investigation, Dr Ersilova admitted adding this false information concerning Lidocaine, calcium gluconate and CPR, saying during interview that she was aware it was serious professional misconduct and that she was prepared to take the consequences. Vets Now reported the matter to the RCVS.
The Committee considered that all evidence before it fully supported the charges against Dr Ersilova, that her conduct was clearly dishonest, and that her actions were inexcusable, especially for someone as experienced as she was. It stated that a veterinary surgeon's duty to make only truthful and accurate records was so manifest and well known to veterinary surgeons that there could be no real excuse to make such false, misleading and dishonest entries.
The Committee highlighted the comment by Dr Ersilova that she knew she had done something wrong but did not expect her colleague to report her, as providing no explanation, or excuse, for doing something which she knew to be wrong.
A number of submissions were made to the Committee in mitigation, including that Dr Ersilova had admitted her dishonesty to both her employers and the Committee; had an otherwise unblemished record over 22 years of practice; had received no immediate financial gain by her actions; and, did not cause any animal suffering.
Accepting these submissions, the Committee nevertheless felt it needed to balance them against other factors. Dr Ersilova's decision to falsify the records was premeditated and had not been taken without an opportunity for full reflection. There were numerous entries in the RCVS Code of Professional Conduct that highlighted the importance of professional integrity and accuracy, and, given the importance which the Code attached to the duty of veterinary surgeons to be truthful and honest in all their dealings with their clients, the Committee found Dr Ersilova's conduct to be "most reprehensible".
Speaking on behalf of the Disciplinary Committee, its Vice-Chairman, Professor Sheila Crispin, said: "It is of great importance that the public should be able to retain confidence in the honesty and integrity of members of the profession. Both the public and other members of the profession must be entitled to rely on the truthfulness of what a veterinary surgeon has written in the clinical records of any animal [they have] treated.
"It is [our] decision that the sanction of suspension adequately reflects the seriousness of the [Dr Ersilova's] conduct. The sanction imposed is ... the most appropriate to inform the profession how seriously such dishonest conduct will be taken, because such conduct clearly brings the profession into disrepute and ... cannot and will not be tolerated."
The Committee then concluded that the least period of suspension that could be justified was one of six months.
Virbac has announced that Ovarid is back in stock following the resolution of a manufacturing problem.
The megestrol acetate tablets are indicated for the postponement or prevention of oestrus and the treatment of hypersexuality in male dogs. In cats they are recommended for the prevention or postponement of oestrus and the treatment of miliary dermatitis and eosinophilic granulomata.
Virbac says that because the product is relied on by the owners of many cats suffering from miliary eczema, it has worked to ensure that their welfare is not compromised by recalling unused Ovarid stock from practices to ensure that it could still be provided to those contacting them with emergency cases since the outage began in February.
Senior Product Manager Chris Geddes MRCVS said: "I'd like to express my thanks to practices for bearing with us and particularly to those which returned unused product. This meant that we were able to supply emergency supplies for the treatment of miliary eczema to every practice that asked for it. We also managed to help out some zoos which needed supplies for frisky sea lions and lions."
Ovarid is available in 20mg and 5mg tablets.
CVS has launched a buying group open to independently-owned practices to benefit from the knowledge, experience and strength of the 250 practices which form CVS.
The new buying group is called MiVetClub. It offers a range of services, including:
Sara Armitage, Director of Product and Buying at CVS, said: "There are many thriving independent practices out there which have the potential to be even more successful if they just had the time and expertise to negotiate better deals and had access to the business resources and support to help them run their practices more efficiently and cost-effectively.
"That's where MiVetClub can help. CVS' stature in the veterinary sector means that we can negotiate the very best discounts and rebates for the group's members. But MiVetClub isn't just about saving money. It's also about helping independent practices raise clinical standards and run better businesses. MiVetClub experts are constantly on-hand to advise members on all aspects of running their practice, freeing up their time to concentrate on what they do best, caring for their patients."
For more information, visit: http://www.mivetclub.com/
Elanco has launched the second issue of its dermatology e-newsletter 'Under The Skin', which focuses on fleas and the problem of flea infestations.
Guest edited by Dr Peri Lau-Gillard DerMedVet CertVD DipECVD MRCVS, European Specialist in Veterinary Dermatology, the newsletter reviews the flea life cycle and considers their role as parasite and vector.
Other topics covered include 'seasonal treatment or year round prevention', 'treatment failure - what to consider when the fleas are still alive', 'tips and tricks - flea combing and faecal examination for fleas' and information about spinosad, the active ingredient in Comfortis.
There is also a chance to watch the recent 'real world flea control' webinar presented by flea expert, Dr Mike Dryden, together with a film demonstrating the effect of treatment with a Comfortis tablet on adult fleas.
Issue three of Under The Skin will take a closer look at the flea's role in allergic skin disease and how to manage these sometimes complex and frustrating cases.
To register to receive Elanco's Under The Skin e-newsletter, visit www.thewebinarvet.com/elanco.
Alstoe, maker of a range of veterinary products including Easeflex, Vetergesic, Dolagis and Nelio, has announced that it has changed its name to Sogeval UK Ltd following its acquisition by Sogeval, the French veterinary drug company, earlier this year.
The company says customers will not notice any change to their dealings with the company, because Sogeval UK Ltd will trade from the same premises near York and with the same staff members.
Niall McFerran, Sogeval Country Manager, UK and ROI said: "The change of name to Sogeval UK Ltd aligns the business to one of the world's fastest growing Animal Health companies. Through Sogeval's research and development programmes, we look forward to exciting improvements in the future."
For any questions relating to the change, practices are invited to contact Niall McFerran on 01347 878606.